Home | Publications | Therapeutic | Oncology place holder

Oncology Therapeutic Sector

In this section you will find information products, including market insight and company profiles.

Stay up-to-date with new products added to this category

place holder place holder place holder place holder place holder place holder

Oncology

Title Sort Publication Date Sort Price Sort
place holder

Pipeline Insight: Breast Cancer
Recent approvals increase pressure on pipeline candidates

 April 2008 £6000
Pipeline Insight: Non-Small Cell Lung Cancer
Pipeline set to offer only modest improvements

 April 2008 £6000
The Deployment of Antibody Technologies for the Advancement of Cancer Therapeutics

 April 2008 £1795
Textbook of Surgical Oncology

 November 2007 £125
Decoding Big Pharma's R&D Strategy in Oncology

 September 2007 £1665
Decoding Big Pharma's R&D Strategy in Oncology

 September 2007 £1665
Decoding Big Pharma's R&D Strategy in Oncology

 September 2007 £1665
Gastrointestinal Oncology
Evidence and Analysis

 June 2007 £115
Targeted Therapies in Oncology

 May 2007 £100
Triple Analysis: Apoptosis Agents, Antibodies and Vaccines in Oncology

 December 2006 £2340
An Evaluation of Products and Technologies for Molecular Diagnostics within Oncology

 May 2006 £3140
Partneringdesk deals and alliances in oncology

 April 2006 £1250
Strategic Outlook on Protein Kinase Inhibitors in Oncology

 February 2006 £1325
Drug Targets for Breast Cancer

 January 2006 £1095
Oncogenomics
The Future of Cancer Care

 January 2006 £1945
Analytical Tool - Analysis of Colorectal Cancer R&D
The Complete Guide

 September 2005 £2105
Oncology Brand Commercialization
Resource Allocation

 May 2005 £1665
Pipeline Insight: Hematological malignancies
Targeted treatments and immunotherapy infuse new blood

 April 2005 £6000
Market Leaders in Oncology 2004
Roche and Genentech Continue to Blaze a Trail

 January 2005 £2000
Pipeline Insight: Colorectal Cancer
Avastin and Erbitux Pave The Way For Pipeline Targeted Therapies

 July 2004 £6000
Emerging Cancer Therapies
Markets and Business Opportunities

 June 2002 £875
place holder